bioRxiv Science⌕ Search

Biology subjects

Krishnadas, R.

Publications and source records attributed to Krishnadas, R..

4 recordsLinked to original sources

Hsa-MiR-483 -3p Regulates the Extracellular Matrix Proteins via TGFbeta2/SMAD4 Signaling in the Glucocorticoid-responsive Human Trabecular Meshwork Cells

PurposeTo investigate the role of hsa-miR-483-3p on the regulation of extracellular matrix (ECM) in cultured human trabecular meshwork (HTM) cells with known steroid response. MethodsPrimary cultures of HTM cells with known steroid responsiveness [GC-responder (GC-R) and GC-Non-responder (GC-NR) cells] were grown on coverslip in 12-well plate until 80% confluence and treated with 100 nM dexamethasone (DEX) for 24 h and transfected with different concentrations of synthetic miRNA 483-3p mimic or inhibitor. After 24 h or 72 h post transfection, the cells were harvest for the following experiments: (i) percentage transfection efficiency (ii) RNA isolation for qPCR analysis and (iii) immunofluorescence staining, (iv) protein isolation for Western blotting respectively. All experiments were performed in triplicate with three biological samples (n{square}={square}3). ResultsGC-R HTM cells showed significantly higher expression of SMAD4 as compared to GC-NR HTM cells. Similarly, DEX treatment up-regulated the SMAD4-dependent ECM proteins. The presence of a miR-483-3p mimic down-regulated SMAD4 expression and SMAD4-dependent ECM production in a dose-dependent manner by negatively down- regulating SMAD4/TGF-{beta}2 signalling. The inhibition of SMAD4-dependent ECM production by miR-483-3p was more pronounced in GC-R HTM cells as compared to GC- NR cells. ConclusionThe down-regulation in ECM production by miR-483-3p is SMAD4 dependent and may play a protective role in mitigating steroid response in GC-R HTM cells. Using miR-483-3p mimics demonstrates therapeutic potential for the management of steroid induced ocular hypertension and glaucoma.

cell biology↗

Small RNA Sequencing Reveals a Distinct MicroRNA Signature between Glucocorticoid Responder and Glucocorticoid Non-responder Primary Human Trabecular Meshwork Cells after Dexamethasone Treatment

The present study aimed to understand the role of miRNAs in differential glucocorticoid (GC) responsiveness in human trabecular meshwork (HTM) cells using small RNA sequencing. For this, total RNA was extracted from cultured HTM cells with known GC responsiveness using Human organ-cultured anterior segment (HOCAS) (GC-responder GC-R; n=4) and GC-non-responder (GC-NR; n=4) after treatment with either 100nM dexamethasone (DEX) or ethanol (ETH) for 7 days. Differentially expressed miRNAs (DEMIRs) were compared among 5 groups and validated by RT-PCR. There were 13 and 21 DEMIRs identified in Group #1 (ETH vs DEX-treated GC-R) and Group #2 (ETH vs DEX-treated GC-NR) respectively. Seven miRNAs were found as common miRNAs dysregulated in both GC-R and GC-NR (Group #3). There were 6 and 14 unique DEMIRs were identified in GC-R (Gropu#4) and GC-NR (Group#5) HTM cells respectively. Ingenuity Pathway Analysis identified enriched pathways and biological processes associated with differential GC responsiveness in HTM cells. Integrative analysis of miRNA-mRNA of the same set of HTM cells revealed several molecular regulators for GC non-responsiveness. This is the first study revealed a unique miRNA signature between GC-R and GC-NR HTM cells which raises the possibility of developing new molecular targets for the management of steroid-OHT/glaucoma.

cell biology↗

A Comparative Genome-wide Transcriptome Analysis of Glucocorticoid Responder and Non-Responder Primary Human Trabecular Meshwork Cells

The genome-wide gene expression analysis of primary human trabecular meshwork (HTM) cells with known glucocorticoid (GC) responsiveness was not reported earlier. Therefore, the purpose of this study was to investigate genes and pathways involved in the GC responsiveness in human trabecular meshwork (HTM) cells using RNA sequencing. A perfusion cultured human anterior segment ex vivo model was utilized to identify the induction of GC-induced ocular hypertension in one eye of a paired eyes after dexamethasone treatment based on the maximum intraocular pressure response and in the contralateral eye, HTM cells were isolated to classify GC-responder and non-responder cells. Some previously reported and unique genes and their associated pathways were identified in HTM cells in response to dexamethasone treatment versus vehicle control and more significantly in GC-responder and non-responder cells. This study will open up the possibility of identifying suitable molecular targets which have the potential to treat GC-induced ocular hypertension/glaucoma.

genomics↗

Predicting One-Year Outcome in First Episode Psychosis using Machine Learning

Lay SummaryO_ST_ABSEvidence before this studyC_ST_ABSOur knowledge of factors which predict outcome in first episode psychosis (FEP) is incomplete. Poor premorbid adjustment, history of developmental disorder, symptom severity at baseline and duration of untreated psychosis are the most replicated predictors of poor clinical, functional, cognitive, and biological outcomes. Yet, such group level differences are not always replicated in individuals, nor can observational results be clearly equated with causation. Advanced machine learning techniques have potential to revolutionise medicine by looking at causation and the prediction of individual patient outcome. Within psychiatry, Koutsouleris et al employed machine learning to predict 4- and 52-week functional outcome in FEP to a 75% and 73.8% test-fold balanced accuracy on repeated nested internal cross-validation. The authors suggest that before employing a machine learning model \"into real-world care, replication is needed in external first episode samples\".\n\nAdded value of this studyWe believe our study to be the first externally validated evidence, in a temporally and geographically independent cohort, for predictive modelling in FEP at an individual patient level. Our results demonstrate the ability to predict both symptom remission and functioning (in employment, education or training (EET)) at one-year. The performance of our EET model was particularly robust, with an ability to accurately predict the one-year EET outcome in more than 85% of patients. Regularised regression results in sparse models which are uniquely interpretable and identify meaningful predictors of recovery including specific individual PANSS items, and social support. This builds on existing studies of group-level differences and the elegant work of Koutsouleris et al.\n\nImplications of all the available evidenceWe have demonstrated the externally validated ability to accurately predict one-year symptomatic and functional status in individual patients with FEP. External validation in a plausibly related temporally and geographically distinct population assesses model transportability to an untested situation rather than simply reproducibility alone. We propose that our results represent important and exciting progress in unlocking the potential of predictive modelling in psychiatric illness. The next step prior to implementation into routine clinical practice would be to establish whether, by the accurate identification of individuals who will have poor outcomes, we can meaningful intervene to improve their prognosis.\n\nAbstractO_ST_ABSBackgroundC_ST_ABSEarly illness course correlates with long-term outcome in psychosis. Accurate prediction could allow more focused intervention. Earlier intervention corresponds to significantly better symptomatic and functional outcomes.\n\nWe use routinely collected baseline demographic and clinical characteristics to predict employment, education or training (EET) status, and symptom remission in patients with first episode psychosis (FEP) at 1 year.\n\nMethods83 FEP patients were recruited from National Health Service (NHS) Glasgow between 2011 and 2014 to a 24-month prospective cohort study with regular assessment of demographic and psychometric measures. An external independent cohort of 79 FEP patients were recruited from NHS Glasgow and Edinburgh during a 12-month study between 2006 and 2009.\n\nElastic net regularised logistic regression models were built to predict binary EET status, period and point remission outcomes at 1 year on 83 Glasgow patients (training dataset). Models were externally validated on an independent dataset of 79 patients from Glasgow and Edinburgh (validation dataset). Only baseline predictors shared across both cohorts were made available for model training and validation.\n\nOutcomesAfter excluding participants with missing outcomes, models were built on the training dataset for EET status, period and point remission outcomes and externally validated on the validation dataset. Models predicted EET status, period and point remission with ROC area under curve (AUC) performances of 0.876 (95%CI: 0.864, 0.887), 0.630 (95%CI: 0.612, 0.647) and 0.652 (95%CI: 0.635, 0.670) respectively. Positive predictors of EET included baseline EET and living with spouse/children. Negative predictors included higher PANSS suspiciousness, hostility and delusions scores. Positive predictors for symptom remission included living with spouse/children, and affective symptoms on the Positive and Negative Syndrome Scale (PANSS). Negative predictors of remission included passive social withdrawal symptoms on PANSS.\n\nInterpretationUsing advanced statistical machine learning techniques, we provide the first externally validated evidence for the ability to predict 1-year EET status and symptom remission in FEP patients.\n\nFundingThe authors acknowledge financial support from NHS Research Scotland, the Chief Scientist Office, the Wellcome Trust, and the Scottish Mental Health Research Network.

neuroscience↗